Community Mental Health Journal

, Volume 53, Issue 6, pp 736–746 | Cite as

Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria

  • Victor Olufolahan Lasebikan
  • Joachim Azegbeobor
Original Paper

Abstract

To examine prevalence of medical comorbidity (MCM) in schizophrenia (n = 1310) and in bipolar disorder (n = 1307) and the association of high burden of MCM (≥3 MCM) with duration of untreated illness, number of episodes, functioning, poly-medication and lifetime hospitalization for the mental disorder. Participants were recruited from a private psychiatric facility in Ibadan, Nigeria between 2004 and 2013 and enquiry made about the lifetime occurrence of 20 common chronic diseases including common tropical diseases. Psychiatric diagnosis was made using the Structured Clinical Interview for DSM IV Axis I disorder (SCID). Except for nutritional anemia, dermatitis and intestinal Helminthiasis, patients with schizophrenia were not at higher odds of reporting MCM than those with bipolar disorder. DUI ≥2 years, episodes of illness ≥3, being on multiple neuroleptics and history of previous hospitalization were significantly associated with high burden of MCM in schizophrenia and episodes of illness ≥3, reduced functioning and history of previous hospitalization with bipolar disorder. Schizophrenia and bipolar disorder are associated with high rates of medical comorbidity. Treatment of this medical comorbidity is essential in order to improve the outcomes for patients with bipolar disorder and schizophrenia.

Keywords

Schizophrenia Bipolar disorder Infections Nutritional anaemia Medical-co-morbidity 

References

  1. Alao, A. O., & Yolles, J. C. (1998). Isoniazid-induced psychosis. The Annals of Pharmacotherapy, 32(9), 889–891.CrossRefPubMedGoogle Scholar
  2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders. In (Eds.), (4th ed.). Washington DC: A. P. Association.Google Scholar
  3. Avram, A. M., Patel, V., Taylor, H. C., Kirwan, J. P., & Kalhan, S. (2001). Euglycemic clamp study in clozapine-induced diabetic ketoacidosis. The Annals of Pharmacotherapy, 35(11), 1381–1387.CrossRefPubMedGoogle Scholar
  4. Baethge, C., Blumentritt, H., Berghöfer, A., Bschor, T., Glenn, T., Adli, M.,… Finke, R. (2005). Long-term lithium treatment and thyroid antibodies: A controlled study. Journal of Psychiatry and Neuroscience, 30(6), 423–427.PubMedPubMedCentralGoogle Scholar
  5. Bergamo, C., Sigel, K., Mhango, G., Kale, M., & Wisnivesky, J. P. (2014). Inequalities in lung cancer care of elderly patients with schizophrenia: An observational cohort study. Psychosomatic Medicine, 76(3), 215–220.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bradley, A. J., & Dinan, T. G. (2010). A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: Implications for mortality. Journal of Psychopharmacology (Oxford, England), 24(4_supplement), 91–118. doi:10.1177/1359786810385491.
  7. Carney, C. P., Jones, L., & Woolson, R. F. (2006). Medical comorbidity in women and men with schizophrenia: A population-based controlled study. Journal of General Internal Medicine Official Journal of the Society for Research and Education in Primary Care Internal Medicine, 21(11), 1133–1137.CrossRefGoogle Scholar
  8. Center for Disease Control and Prevention. (2001). CDC in Nigeria. Retrieved February 24, 2015, from http://www.cdc.gov/globalhealth/countries/nigeria/pdf/nigeria.pdf.
  9. Chaturvedi, S. K., & Upadhyaya, M. (1988). Secondary mania in a patient receiving isonicotinic acid hydrazide and pyridoxine: case report. Canadian Journal Psychiatry, 33(7), 675–676.CrossRefGoogle Scholar
  10. Crow, T. J. (1995). A continuum of psychosis, one human gene, and not much else—the case for homogeneity. Schizophrenia Research, 17(2), 135–145.CrossRefPubMedGoogle Scholar
  11. De Hert, M., Cohen, D., Bobes, J., Cetkovich-Bakmas, M., Leucht, S., Ndetei, D. M.,… Correll, C. U. (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry, 10(2), 138–151.CrossRefPubMedGoogle Scholar
  12. De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I., & Moller, H. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry: The Journal of the Association of European Psychiatrists, 24(6), 412–424.CrossRefGoogle Scholar
  13. de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2–3), 135–157.CrossRefPubMedGoogle Scholar
  14. Depp, C. A., Strassnig, M., Mausbach, B. T., Bowie, C. R., Wolyniec, P., Thornquist, M. H.,… Harvey, P. D. (2014). Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disorders, 16(4), 422–431. doi:10.1111/bdi.12200.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., & Lehman, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. The Journal of Nervous and Mental Disease, 187(8), 496–502.CrossRefPubMedGoogle Scholar
  16. Domingo-Claros, A., Alonso, E., & Banda Ed Ede, L. (2004). Schizophrenia and refractory anaemia with ring sideroblasts. British Journal Haematol, 125(5), 543.CrossRefGoogle Scholar
  17. Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001). Quality of medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry, 58(6), 565–572.CrossRefPubMedGoogle Scholar
  18. Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766–771.CrossRefPubMedGoogle Scholar
  19. First, M., Spitzer, R., Gibbon, M., & Williams, J. (1996). Structured clinical interview for DSM-IV Axis I disorders, clinical version, SCID-CV. Washington, DC: American Psychiatric Press, Inc.Google Scholar
  20. Folsom, D. P., McCahill, M., Bartels, S. J., Lindamer, L. A., Ganiats, T. G., & Jeste, D. V. (2002). Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatric Services, 53(11), 1456–1460.CrossRefPubMedGoogle Scholar
  21. Forlenza, O. V., Filho, A. H., Nobrega, J. P., dos Ramos Machado, L., de Barros, N. G., de Camargo, C. H., & da Silva, M. F. (1997). Psychiatric manifestations of neurocysticercosis: A study of 38 patients from a neurology clinic in Brazil. Journal of Neurology, Neurosurgery, and Psychiatry, 62(6), 612–616.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Forty, L., Ulanova, A., Jones, L., Jones, I., Gordon-Smith, K., Fraser, C.,… Craddock, N (2014). Comorbid medical illness in bipolar disorder. The British Journal of Psychiatry, 205(6), 465–472. doi:10.1192/bjp.bp.114.152249.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Garcia-Portilla, M. P., Saiz, P. A., Benabarre, A., Sierra, P., Perez, J., Rodriguez, A.,… Bobes, J (2008). The prevalence of metabolic syndrome in patients with bipolar disorder. Journal of Affective Disorders, 106(1–2), 197–201. doi:10.1016/j.jad.2007.06.002.CrossRefPubMedGoogle Scholar
  24. Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992). Revising axis V for DSM-IV: A review of measures of social functioning. The American Journal of Psychiatry, 149(9), 1148–1156.CrossRefPubMedGoogle Scholar
  25. Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009). Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders, 11(6), 657–662. doi:10.1111/j.1399-5618.2009.00735.x.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Gureje, O., Herrman, H., Harvey, C., Morgan, V., & Jablensky, A. (2002). The Australian National Survey of Psychotic Disorders: Profile of psychosocial disability and its risk factors. Psychological Medicine, 32(4), 639–647.CrossRefPubMedGoogle Scholar
  27. Gureje, O., Lasebikan, V. O., Ephraim-Oluwanuga, O., Olley, B. O., & Kola, L. (2005). Community study of knowledge of and attitude to mental illness in Nigeria. The British Journal of Psychiatry, 186(5), 436–441. doi:10.1192/bjp.186.5.436.CrossRefPubMedGoogle Scholar
  28. Jacquelin, A., Gratay, A., Chiron, J. P., Olivo, H. R., Schwartz, B., & Schwartz, D. (1967). Atypical psychotic tuberculosis. Sem Hop, 43(49), 3092–3099.PubMedGoogle Scholar
  29. Kerner, B. (2014). Comorbid substance use disorders in schizophrenia: A latent class approach. Psychiatry Research, 15(14), 00989–00985.Google Scholar
  30. Khandaker, G. M., Zammit, S., Lewis, G., & Jones, P. B. (2014). A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophrenia Research, 152(1), 139–145.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Kilbourne, A. M., Cornelius, J. R., Han, X., Pincus, H. A., Shad, M., Salloum, I.,… Haas, G. L. (2004). Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disorders, 6(5), 368–373.CrossRefPubMedGoogle Scholar
  32. Kouidrat, Y., Amad, A., Lalau, J.-D., & Loas, G. (2014). Eating disorders in schizophrenia: Implications for research and management. Schizophrenia Research and Treatment, 2014, 791573. doi:10.1155/2014/791573.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Kredentser, M. S., Martens, P. J., Chochinov, H. M., & Prior, H. J. (2014). Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. The Journal of Clinical Psychiatry, 75(2), 154–161.CrossRefPubMedGoogle Scholar
  34. Kuo, S. C., Chen, Y. T., Li, S. Y., Lee, Y. T., Yang, A. C., Chen, T. L.,…Fung, C. P. (2013). Incidence and outcome of newly-diagnosed tuberculosis in schizophrenics: A 12-year, nationwide, retrospective longitudinal study. BMC Infectious Diseases, 13(351), 1471–2334.Google Scholar
  35. Langlois, M. C., Beaudry, G., Zekki, H., Rouillard, C., & Levesque, D. (2001). Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience, 106(1), 117–128.CrossRefPubMedGoogle Scholar
  36. Lasebikan, V., & Ayinde, O. (2013). Family burden in caregivers of schizophrenia patients: Prevalence and socio-demographic correlates. Indian Journal Psychological Medicine, 35(1), 60–66. doi:10.4103/0253-7176.112205.CrossRefGoogle Scholar
  37. Lasebikan, V. O. (2014). Tobacco smoking and medical co-morbidities among patients with schizophrenia in a Nigerian clinical setting. African Journal of Medicine and Medical Sciences, 43(4), 315–325.PubMedGoogle Scholar
  38. Laursen, T. M., Munk-Olsen, T., Nordentoft, M., & Mortensen, P. B. (2007). Increased mortality among patients admitted with major psychiatric disorders: A register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. The Journal of Clinical Psychiatry, 68(6), 899–907.CrossRefPubMedGoogle Scholar
  39. Lawrence, D., & Kisely, S. (2010). Inequalities in healthcare provision for people with severe mental illness. Journal of Psychopharmacology, 24(4 Suppl), 61–68. doi:10.1177/1359786810382058.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007). Physical illness and schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica, 116(5), 317–333. doi:10.1111/j.1600-0447.2007.01095.x.CrossRefPubMedGoogle Scholar
  41. Li, M., Fan, Y. L., Tang, Z. Y., & Cheng, X. S. (2014). Schizophrenia and risk of stroke: a meta-analysis of cohort studies. International Journal Cardiology, 173(3):588–90. doi:10.1016/j.ijcard.2014.03.101. (Epub 2014 Mar 21).CrossRefGoogle Scholar
  42. Liao, C. H., Chang, C. S., Chang, S. N., Muo, C. H., Lane, H. Y., Sung, F. C., & Kao, C. H. (2014). The association of peptic ulcer and schizophrenia: A population-based study. Journal of Psychosomatic Research, 77(6), 541–546.CrossRefPubMedGoogle Scholar
  43. Livingstone, C., & Rampes, H. (2006). Lithium: A review of its metabolic adverse effects. Journal of Psychopharmacology, 20(3), 347–355.CrossRefPubMedGoogle Scholar
  44. Maj, M. (2009). Physical health care in persons with severe mental illness: A public health and ethical priority. World Psychiatry, 8(1), 1–2.CrossRefPubMedPubMedCentralGoogle Scholar
  45. McIntyre, J. S., & Romano, J. (1977). IS there a stethoscope in the house (and is it used)? Archives of General Psychiatry, 34(10), 1147–1151. doi:10.1001/archpsyc.1977.01770220029002.CrossRefPubMedGoogle Scholar
  46. McIntyre, R. S., Konarski, J. Z., Soczynska, J. K., Wilkins, K., Panjwani, G., Bouffard, B.,… Kennedy, S. H. (2006). Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatric Services, 57(8), 1140–1144.CrossRefPubMedGoogle Scholar
  47. McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012). Lithium toxicity profile: A systematic review and meta-analysis. Lancet, 379(9817), 721–728. doi:10.1016/s0140-6736(11)61516-x.CrossRefPubMedGoogle Scholar
  48. McPherson, S., Barbosa-Leiker, C., Daratha, K., Short, R., McDonell, M. G., Alicic, R.,… Tuttle, K. (2014). Association of co-occurring serious mental illness with emergency hospitalization in people with chronic kidney disease. American Journal of Nephrology, 39(3), 260–267.CrossRefPubMedGoogle Scholar
  49. Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011). Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biological Psychiatry, 70(7), 663–671.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Morden, N. E., Lai, Z., Goodrich, D. E., MacKenzie, T., McCarthy, J. F., Austin, K.,… Kilbourne, A. M. (2012). Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia. General Hospital Psychiatry, 34(4), 368–379. doi:10.1016/j.genhosppsych.2012.02.009.CrossRefPubMedPubMedCentralGoogle Scholar
  51. Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research, 71(2–3), 405–416. doi:10.1016/j.schres.2004.03.002.CrossRefPubMedGoogle Scholar
  52. National Population Commission of Nigeria. (2014). National population facts and figures. From http://www.population.gov.ng/index.php.htm.
  53. Proakis, A. G., Mennear, J. H., Miya, T. S., & Borowitz, J. L. (1971). Phenothiazine-induced hyperglycemia: Relation to CNS and adrenal effects. Proceedings of the Society for Experimental Biology and Medicine, 137(4), 1385–1388.CrossRefPubMedGoogle Scholar
  54. Radhakrishnan, R., Calvin, S., Singh, J. K., Thomas, B., & Srinivasan, K. (2013). Thyroid dysfunction in major psychiatric disorders in a hospital based sample. The Indian Journal of Medical Research, 138(6), 888–893.PubMedPubMedCentralGoogle Scholar
  55. Razzano, L. A., Cook, J. A., Yost, C., Jonikas, J. A., Swarbrick, M. A., Carter, T. M., & Santos, A. (2014). Factors associated with co-occurring medical conditions among adults with serious mental disorders. Schizophrenia research, 6(14), 00698–00697.Google Scholar
  56. Schrader, G., Cheok, F., Hordacre, A. L., Marker, J., & Wade, V. (2005). Effect of psychiatry liaison with general practitioners on depression severity in recently hospitalised cardiac patients: A randomised controlled trial. The Medical Journal of Australia, 182(6), 272–276.PubMedGoogle Scholar
  57. Sicras-Mainar, A., Maurino, J., Ruiz-Beato, E., & Navarro-Artieda, R. (2014). Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 51–57.PubMedPubMedCentralGoogle Scholar
  58. Smith, D. J., Martin, D., McLean, G., Langan, J., Guthrie, B., & Mercer, S. W. (2013). Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: A cross sectional study. BMC Medicine, 11(263), 1741–7015.Google Scholar
  59. Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., & Dixon, L. B. (2004). Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. The Journal of Nervous and Mental Disease, 192(6), 421–427.CrossRefPubMedGoogle Scholar
  60. Soreca, I., Fagiolini, A., Frank, E., Houck, P. R., Thompson, W. K., & Kupfer, D. J. (2008). Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. Journal of Psychiatric Research, 42(11), 956–961.CrossRefPubMedGoogle Scholar
  61. Strain, J. J., Lyons, J. S., Hammer, J. S., Fahs, M., Lebovits, A., Paddison, P. L.,… Sacks, C. (1991). Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients. The American Journal of Psychiatry, 148(8), 1044–1049.CrossRefPubMedGoogle Scholar
  62. Tidemalm, D., Waern, M., Stefansson, C. G., Elofsson, S., & Runeson, B. (2008). Excess mortality in persons with severe mental disorder in Sweden: A cohort study of 12 103 individuals with and without contact with psychiatric services. Clinical Practice Epidemiology Mental Health, 4, 23. doi:10.1186/1745-0179-4-23.Google Scholar
  63. Torrey, E. F., Bartko, J. J., & Yolken, R. H. (2012). Toxoplasma gondii and other risk factors for schizophrenia: An update. Schizophrenia Bulletin, 38(3), 642–647.CrossRefPubMedPubMedCentralGoogle Scholar
  64. Tret’iakov, A., Shilenok, V. N., Karpov, A. G., Polushin, P. I., Zakharchenko, S. P., & Leukhin, I. N. (2012). Ulcer disease in schizophrenic patients as a model for the estimation of neurogenic factors predisposing to a somatic disease. Klinicheskaia Meditsina, 90(2), 39–43.PubMedGoogle Scholar
  65. Wirshing, D. A., Spellberg, B. J., Erhart, S. M., Marder, S. R., & Wirshing, W. C. (1998). Novel antipsychotics and new onset diabetes. Biological Psychiatry, 44(8), 778–783.CrossRefPubMedGoogle Scholar
  66. Wise, B. L., Niu, J., Zhang, Y., Wang, N., Jordan, J. M., Choy, E., & Hunter, D. J. (2010). Psychological factors and their relation to osteoarthritis pain. Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society, 18(7), 883–887.CrossRefPubMedCentralGoogle Scholar
  67. World Health Organization. (2004). Global Status Report Geneva. World Health Organization.Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Victor Olufolahan Lasebikan
    • 1
  • Joachim Azegbeobor
    • 2
  1. 1.Consultation Liaison Unit, Department of PsychiatryUniversity College HospitalIbadanNigeria
  2. 2.Department of PsychiatryUniversity College Hospital, IbadanIbadanNigeria

Personalised recommendations